Gerontology

Clinical Section

Tetanus in the Elderly: Is It Different from That in Younger Age Groups?

Khajehdehi P. · Rezaian G.-R.

Author affiliations

Intensive Care Unit, Department of Internal Medicine, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran

Related Articles for ""

Gerontology 1998;44:172–175

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Clinical Section

Published online: April 18, 1998
Issue release date: May – June

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 3

ISSN: 0304-324X (Print)
eISSN: 1423-0003 (Online)

For additional information: https://www.karger.com/GER

Abstract

Our aims were to itemize the clinical features and the outcome of tetanus in the elderly, as well as any age and sex differences in its acquisition. Therefore, we compared the demographic and clinical data of 12 elderly (group 1) cases of tetanus with 69 middle-aged patients (group 2) and 12 children (group 3) suffering from the same disease. There was no significant difference between the site of entry and incubation period or in the clinical and paraclinical findings among the three groups of patients. Acute respiratory failure was found more commonly in group 1 than in groups 2 and 3 (p = 0.0167 and p = 0.0006, respectively). It was also more common in group 2 than in group 3 (p = 0.0140). A mild form of tetanus was more often detected in children than in middle-aged and elderly cases (p = 0.0213 and p = 0.0013, respectively). Severe tetanus was seen more often in group 1 than in groups 2 and 3 (p = 0.0167 and p = 0.0006, respectively). Despite this, the mortality rate was not statistically different among the three groups of patients. Females were affected much less frequently than males with a female:male ratio of 1:3 in all three age groups. Our results suggest that elderly patients are at higher risk of acquiring a more severe form of tetanus and the subsequent development of acute respiratory failure. In addition, the disease is more common in males of all age groups, and age and sex have no apparent effect on the outcome of patients with tetanus.




Related Articles:


References

  1. Richardson JP, Knight AL: The prevention of tetanus in elderly. Arch Intern Med 1991;151:1712–1717.
  2. Richardson JP, Knight AL: The management and prevention of tetanus. J Emerg Med 1993;11:737–742.
  3. Nandi SR, Ghosh SK: Tetanus in a 92-year-old man. Br J Clin Pract 1988;42:78–79.
    External Resources
  4. Shreve ST, Spivak B: Tetanus in a 74-year-old woman. J Am Geriatr Soc 1994;42:424–425.
  5. Weiss BP, Strassburg MA, Feeley JC: Tetanus and diphtheria immunity in an elderly population in Los Angeles Country. Am J Public Health 1983;73:802–804.
  6. Jenkins MT, Luhn NR: Active management of tetanus. Anesthesiology 1962;23:690–709.
  7. Weinstein L: Tetanus. N Engl J Med 1973;289:1293–1296.
    External Resources
  8. Trujillo MJ, Castillo A, Espana J, Guevara P, Eganez H: Tetanus in the adult: Intensive care and management experience with 233 cases. Crit Care Med 1980;8:419–423.
    External Resources
  9. Kerr JH, Corbett JL, Prys-Roberts C, Crampton Smith A, Spalding JMK: Involvement of the sympathetic nervous system in tetanus: Studies on 82 cases. Lancet 1968;ii:236–241.
  10. Prys-Roberts C, Corbett JL, Kerr JH, Spalding JMK, Crampton Smith A: Treatment of sympathetic over-activity in tetanus. Lancet 1969;i:542–545.
  11. Kloetzel K: Clinical patterns in severe tetanus. JAMA 1963;185:559–567.
  12. Andrews J, Marcus A, Muirhead KM: A fatal case of tetanus: Treated by suxamethonium chloride, tracheotomy, and intermittent positive-pressure respiration. Lancet 1956;ii:652–653.
  13. Koblin BA, Townsend TR: Immunity to diphtheria and tetanus in inner-city women of childbearing age. Am J Public Health 1989;79:1297–1298.
    External Resources
  14. Levine L, Wyman L: Survey of immunity by serologic methods: Results of three successive surveys of samples of the Massachusetts population for diphtheria and tetanus antitoxin. N Engl J Med 1965;272:23–26.
  15. West JB: Other tests; in West JB (ed): Pulmonary Pathophysiology. Baltimore, Williams & Wilkins, 1982, pp 42–56.
  16. Rodrigues CJ, Rodrigues AJ Jr, Bohm GM: Effect of aging on muscle fibers and collagen content of the diaphragm: A comparison with the rectus abdominis muscle. Gerontology 1996;42:218–228.

Article / Publication Details

First-Page Preview
Abstract of Clinical Section

Published online: April 18, 1998
Issue release date: May – June

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 3

ISSN: 0304-324X (Print)
eISSN: 1423-0003 (Online)

For additional information: https://www.karger.com/GER


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP